Overview

NCI Definition: A malignant neoplasm of the pleura or peritoneum, arising from mesothelial cells. It is associated with exposure to asbestos. [1]

Malignant mesotheliomas most frequently harbor alterations in BAP1, NF2, CDKN2A, CDKN2B, and SETD2 [2].

Most Commonly Altered Genes in Malignant Mesothelioma

BAP1 Mutation, CDKN2A Loss, NF2 Mutation, CDKN2B Loss, and SETD2 Mutation are the most common alterations in malignant mesothelioma [2].

Top Alterations in Malignant Mesothelioma

Significant Genes in Malignant Mesothelioma

BAP1 +

NF2 +

Disease Details

Synonyms
Malignant Mesothelial Neoplasm, Malignant Neoplasm of Mesothelium, Malignant Tumor of Mesothelium, Malignant Mesothelial Tumor, Malignant Neoplasm of the Mesothelium, MESOTHELIOMA, MALIGNANT, Malignant Tumor of the Mesothelium
Parent(s)
Mesothelioma
Children
Advanced Malignant Mesothelioma, Pericardial Malignant Mesothelioma, Epithelioid Mesothelioma, Ovarian Malignant Mesothelioma, Sarcomatoid Mesothelioma, Biphasic Mesothelioma, Peritoneal Malignant Mesothelioma, and Malignant Pleural Mesothelioma

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 4. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.